Observation on the clinical efficacy of acupuncture combined with traditional Chinese medicine in the treatment of acute exacerbation phase of chronic obstructive pulmonary disease
针灸联合中药治疗慢阻肺急性加重期的临床疗效观察

摘要

目的 为探讨针灸联合中药对慢性阻塞性肺疾病急性加重期（AECOPD）患者的临床价值。方法 我们选取2024年1月-2025年12月我院收治的80例AECOPD患者开展随机对照研究。受试者被随机分为对照组与观察组，各40例。对照组采用常规西医治疗，观察组在其基础上加用针灸联合中药辨证治疗，疗程均为2周。结果 从临床疗效来看，观察组总有效率显著高于对照组。治疗后，两组患者的肺功能指标均较治疗前有所改善，且观察组的改善幅度更为明显。炎症因子水平方面，两组患者治疗后均出现下降，观察组的下降幅度显著大于对照组。中医证候积分、呼吸困难评分及CAT评分的变化趋势相似，两组均较治疗前降低，且观察组的评分水平更低。值得注意的是，两组患者的不良反应发生率并无统计学差异（P>0.05）。结论 综合以上结果可以认为，针灸联合中药治疗AECOPD能够显著提升临床疗效，有效改善患者肺功能，减轻气道炎症反应，缓解临床症状，提高生活质量，且安全性良好，值得在临床推广应用。

Abstract

Objective To explore the clinical value of acupuncture combined with traditional Chinese medicine in patients with acute exacerbation phase of chronic obstructive pulmonary disease (AECOPD).
Methods We selected 80 patients with AECOPD who were admitted to our hospital from January 2024 to December 2025 for a randomized controlled study. The subjects were randomly divided into the control group and the observation group, with 40 cases in each group. The control group received conventional Western medicine treatment, while the observation group received acupuncture combined with traditional Chinese medicine based on the above treatment, with a treatment course of 2 weeks.
Results From the perspective of clinical efficacy, the total effective rate of the observation group was significantly higher than that of the control group. After treatment, the pulmonary function indicators of both groups improved compared with those before treatment, and the improvement in the observation group was more obvious. Regarding inflammatory factor levels, both groups showed a decrease after treatment, and the decrease in the observation group was significantly greater than that of the control group. The changes in TCM syndrome scores, dyspnea scores, and CAT scores were similar, and both groups decreased compared with those before treatment, and the score level of the observation group was lower. It should be noted that there was no statistically significant difference in the incidence of adverse reactions between the two groups (P > 0.05).
Conclusion   Based on the above results, it can be concluded that acupuncture combined with traditional Chinese medicine for the treatment of AECOPD can significantly improve clinical efficacy, effectively improve pulmonary function, reduce airway inflammatory responses, relieve clinical symptoms, improve quality of life, and has good safety, and is worthy of clinical promotion and application.